Sant Kumar & Michael J. Blaha. (2024). GLP-1 RA for cardiometabolic risk reduction in obesity - How do we best describe benefit and value? Elsevier.
Chicago Style (17th ed.) CitationSant Kumar and Michael J. Blaha. GLP-1 RA for Cardiometabolic Risk Reduction in Obesity - How Do We Best Describe Benefit and Value? Elsevier, 2024.
MLA (9th ed.) CitationSant Kumar and Michael J. Blaha. GLP-1 RA for Cardiometabolic Risk Reduction in Obesity - How Do We Best Describe Benefit and Value? Elsevier, 2024.
Warning: These citations may not always be 100% accurate.